Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 5 publications
Nivolumab plus ipilimumab for chemotherapy-refractory metastatic castration-resistant prostate cancer: results from the randomized portion of the phase 2 CheckMate 650 trial.
Journal: Nature communications
Published: July 25, 2025
Different PD-L1 Assays Reveal Distinct Immunobiology and Clinical Outcomes in Urothelial Cancer.
Journal: Cancer immunology research
Published: July 09, 2024
Adjuvant nivolumab in muscle-invasive urothelial carcinoma: exploratory biomarker analysis of the randomized phase 3 CheckMate 274 trial.
Journal: Nature medicine
Published: November 28, 2023
Application of TruGraf v1: A Novel Molecular Biomarker for Managing Kidney Transplant Recipients With Stable Renal Function.
Journal: Transplantation proceedings
Published: October 01, 2018
Investigator Assessment of the Utility of the TruGraf Molecular Diagnostic Test in Clinical Practice.
Journal: Transplantation proceedings
Published: July 14, 2018
Showing 1-5 of 5
Last Updated: 09/26/2026